IN BRIEF: Haleon says Pfizer representative steps down from board

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Haleon PLC - Weybridge, Surrey-based consumer healthcare products - Says Pfizer Inc representative and Non-Executive Director, David Denton, stepped down from Haleon’s board on Wednesday following the reduction of Pfizer’s stake in Haleon to below 20% and in line with the two firms’ relationship agreement. Current Chief Financial Officer of J Sainsbury PLC Blathnaid Bergin will join the Haleon board as non-executive director on February 24.

Current stock price: 377.13 pence, down 0.2% in London on Thursday morning

12-month change: up 17%

Copyright 2024 Alliance News Ltd. All Rights Reserved.